There have been major cuts in 2014 physician fee schedules as compared to 2013.  Imaging centers are feeling top line reimbursement pressure which has directly impacted EBITDA growth over the past few years.  In response to negative growth in reimbursement rates and margins, centers will adapt to change what they have power over, namely expenses.  In this article, we will benchmark 30 freestanding, single site, multi-modality imaging centers for which VMG has had the privilege to provide valuation services. 

Regenerative medicine is generating growing interest in terms of research and market investment, according to a data analysis announced June 18 by Frost & Sullivan.

REM behavior disorder (RBD) is highly correlated with the development and progression of neurodegenerative disease including Parkinson’s, according to a brain study presented during the recent Society of Nuclear Medicine and Molecular Imaging’s 2014 Annual Meeting.

Jigsaw preclinical imaging is not a new concept. However novel instrumentation called Opti-SPECT/PET/CT presented during the 2014 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) held June 7-11 in St. Louis brings together a full spectrum of molecular imaging technology into one system—and one scan. Bioluminescence and fluorescence imaging agents developed with the platform could one day be implemented as intraoperative tracers during surgery, most notably for oncologic procedures.

SPECT and PET can detect the pathology of chronic joint pain due to rheumatoid arthritis when performed with agents that target antifibroblast activation protein (FAP) antibodies, according to a study presented last week during the 2014 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) in St. Louis.

Chemo and radionuclide therapy together with the addition of drugs that make patients more radiosensitive have been shown to diminish and even suppress neuroendeocrine tumors (NETs) from progressing in 70 percent of cases. As a result, peptide receptor chemo-radionuclide therapy may offer patients improved survival rates, according to a study presented at the recent Society of Nuclear Medicine and Molecular Imaging 2014 Annual Meeting held June 7-11 in St. Louis.

Back pain is a burden for most people at some point in their lifetime, but pinpointing the reason for the pain can be tricky. Researchers presenting during the recent Society of Nuclear Medicine and Molecular Imaging 2014 Annual Meeting in St. Louis have found that SPECT/CT in addition to conventional bone scan gets straight to the point of pain, leading to much higher pain relief following intervention.

Together, the American Society for Radiation Oncology (ASTRO) and the American Association of Physicists in Medicine (AAPM) will share details about RO-ILS: Radiation Oncology Incident Learning System, a new, national patient safety initiative to facilitate safer and higher quality radiation oncology care.